We are live on ! Find out more
CGL

Column Group LP Portfolio holdings

AUM $38.6M
1-Year Est. Return 30.92%
This Fund
S&P 500
This Quarter Est. Return
-40.92%
1 Year Est. Return
-30.92%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$38.6M
AUM Growth
-$26.7M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMDZ
1
DELISTED
Immune Design Corp.
IMDZ
$38.6M 100%
3,161,942
– –

Similar funds

RCI
RRJ Capital II Grand Cayman, Cayman Islands $38.8M AUM 0.84% 1-Year Est. Return
RCM
Royal Capital Management New York $37.2M AUM 3.86% 1-Year Est. Return
TIM
TBP Investments Management Dallas, Texas $37.1M AUM 30.88% 1-Year Est. Return
CGI
Caerus Global Investors New York $36.6M AUM 4.69% 1-Year Est. Return
SGC
South Georgia Capital Naperville, Illinois $41M AUM 2.47% 1-Year Est. Return
BC
Balestra Capital New York $42.5M AUM
AIC
Atlantic Investment Company Atlanta, Georgia $34.3M AUM 10.7% 1-Year Est. Return
ACMM
American Capital Mortgage Management Bethesda, Maryland $33.9M AUM 13.41% 1-Year Est. Return

Column Group LP's Q3 2015 Portfolio in Review

As of Q3 2015, Column Group LP held 1 position worth $38.6M, down 41% from $65.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2015: portfolio turnover was 0%. Column Group LP opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Column Group LP's ten largest holdings make up 100% of its $38.6M portfolio in Q3 2015.
  • Column Group LP opened 0 new positions and closed 0 in Q3 2015.
  • Column Group LP's portfolio value fell 41% quarter-over-quarter to $38.6M.

Based on Column Group LP's 13F filing for Q3 2015, filed 6 Nov 2015.